APA citiranje

Leary, A., Le Tourneau, C., Varga, A., Sablin, M., Gomez-Roca, C., Guilbaud, N., . . . Delord, J. (2018). Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer. Invest New Drugs.

Citação norma Chicago

Leary, Alexandra, Christophe Le Tourneau, Andrea Varga, Marie-Paule Sablin, Carlos Gomez-Roca, Nicolas Guilbaud, Aurelie Petain, Mariya Pavlyuk, and Jean-Pierre Delord. "Phase I Dose-escalation Study of F14512, a Polyamine-vectorized Topoisomerase II Inhibitor, in Patients With Platinum-refractory or Resistant Ovarian Cancer." Invest New Drugs 2018.

MLA citiranje

Leary, Alexandra, et al. "Phase I Dose-escalation Study of F14512, a Polyamine-vectorized Topoisomerase II Inhibitor, in Patients With Platinum-refractory or Resistant Ovarian Cancer." Invest New Drugs 2018.